Therapy News and Research

RSS

Nausea and vomiting are most feared of all chemotherapy-related side effects

PediatRx, Inc. today commented on studies which reveal that chemotherapy-induced nausea and vomiting is one of the most feared of all chemotherapy-related side effects. The fear of nausea and subsequent vomiting is many times so significant that patients can develop a condition known as 'anticipatory' nausea, where the patient becomes nauseous primarily as a result of the fear of becoming nauseous.

25 Apr 2011

Enrollment commences in Gore Early TIPS study for ascites at Indiana University Hospital

W. L. Gore & Associates today reported the first patient enrolled in the Gore Early TIPS for Ascites Study. The patient was treated at Indiana University Hospital in Indianapolis, Ind.

25 Apr 2011

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.

25 Apr 2011

New genetic discovery in Pulmonary Fibrosis

A new discovery in a deadly lung disease may change the direction of research while uncovering increased risk for many patients and families. The Coalition for Pulmonary Fibrosis and the Pulmonary Fibrosis Foundation applaud the efforts of scientists that led to the discovery of a genetic variation associated with the MUC5B gene which may increase the risk of developing Pulmonary Fibrosis.

25 Apr 2011

U-M receives Taubman Institute's $100 million gift for innovative medical science

A. Alfred Taubman has become U-M's largest individual donor, with total giving of more than $142 million. His latest gift of $56 million to the A. Alfred Taubman Medical Research Institute, announced today before the University's Board of Regents, will bring his support of innovative medical science at the University of Michigan to a total of $100 million.

25 Apr 2011

Group B streptococci continues to increase risk of sepsis in newborns

Bloodstream infections in newborns can lead to serious complications with substantial morbidity and mortality. What's more, the pathogens responsible for neonatal infections have changed over time. In recent years, however, antibiotic prophylaxis given to at-risk mothers has reduced the incidence of early-onset group B streptococcal infections among their babies.

25 Apr 2011

Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress

More than 1,800 Chinese oncology professionals attended the NCCN 4th Annual Asia Scientific Congress in Shanghai, China, on April 9, 2011, which featured expert faculty from NCCN Member Institutions and thought leaders in cancer care from major Chinese cancer centers.

25 Apr 2011

Medtronic's English Channel swimming competition to raise awareness on ALS

In August 2011, Doug McConnell of Barrington, Illinois, expects to be the 48th person over age 50 to successfully swim across the English Channel. He will be swimming more than 21 grueling miles in memory of his father, David, who passed away from ALS.

From Medtronic 25 Apr 2011

Study shows neutralizing antibodies against GM-CSF can halt MS development

The neutralization of the cytokine GM-CSF could halt the development of multiple sclerosis. This was demonstrated by the research team of the immunologist Burkhard Becher at the University of Zurich in an animal model.

25 Apr 2011

Creative approach can tackle bacterial infections in patients with cystic fibrosis

An over-the-counter drug used to treat diarrhea combined with minocycline, an antibiotic used to treat bacterial infections, could one day change the lives of those living with cystic fibrosis.

25 Apr 2011

JVIR articles highlight SIR's commitment to patient safety in medical imaging

The Society of Interventional Radiology has a long-term commitment to radiation safety, taking a leading role in measuring and assessing radiation dosage; developing educational programs on radiation safety, radiation protection and reduction of skin dosage; and promoting the safety of patients and health care professionals.

22 Apr 2011

Saint Vincent Hospital to build new cancer center in downtown Worcester

Saint Vincent Hospital today announced it has signed a purchase and sale agreement with the CitySquare II Development Co. LLC , to build a medical office building that will house a new comprehensive cancer center in Worcester's CitySquare development. The new center, which represents a $21 million capital investment by Saint Vincent Hospital, is expected to open in January 2013.

22 Apr 2011

Live surgical procedure to repair abdominal aortic aneurysm broadcast to CICE 2011 in Sao Paolo, Brazil

Scott & White Healthcare today teleconferenced one of the world's first live international surgical procedures to repair an abdominal aortic aneurysm to conference attendees in Sao Paolo, Brazil. The meeting, CICE (Current Issues in Comparative Education) 2011, is one of the globe's largest vascular surgery events and includes over 2,000 attendees. The procedure demonstrated the use of an endograft device called a repositionable endoprosthesis.

22 Apr 2011

Transplanting cells from healthy adult livers may help treat genetic liver-lung disorder

Transplanting cells from healthy adult livers may work in treating a genetic liver-lung disorder that affects millions of people worldwide, according to an animal study in the April 18 online edition of the Journal of Clinical Investigation.

22 Apr 2011

HHS awards Eigen two grants from Qualifying Therapeutic Discovery Project

Eigen is the proud recipient of two grant awards from the Qualifying Therapeutic Discovery Project (QTDP) funded by the U.S. Department of Health & Human Services. QTDP tax credits are provided under section 48D of the Internal Revenue Code (IRC), enacted as part of the Patient Protection and Affordable Care Act of 2010 (P.L. 111-148).

22 Apr 2011

Giffords' office: Close gap in traumatic brain-injury care

Staff members for Rep. Gabrielle Giffords, R-Ariz., have become key advocates in a campaign to ensure that the health law guarantees high levels of care for people who suffer traumatic brain injuries.

22 Apr 2011

Research solves challenging problem of industry-scale production of large RNA molecules

Nanotechnology researchers have known for years that RNA, the cousin of DNA, is a promising tool for nanotherapy, in which therapeutic agents can be delivered inside the body via nanoparticles. But the difficulties of producing long-lasting, therapeutic RNA that remains stable and non-toxic while entering targeted cells have posed challenges for their progress.

22 Apr 2011

Teva acknowledges promising results of DEFINE study in MS

We acknowledge the results of the DEFINE study seem promising for patients. It is important to note that as a general rule, results obtained in clinical trials in multiple sclerosis (MS) cannot be compared, unless agents are tested in a head-to-head manner in the same trial.

22 Apr 2011

BioCryst's BCX4208 study results in gout to be presented at EULAR meeting

BioCryst Pharmaceuticals, Inc. announced the presentation of clinical results related to BCX4208 for the treatment of gout at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism in London, England.

22 Apr 2011

Decision Resources: 63% of neurologists select Tysabri as effective MS treatment

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority of surveyed U.S. neurologists selected Biogen Idec/Elan's Tysabri as the most effective therapy for the treatment of relapsing-remitting multiple sclerosis, when compared to other currently available agents.

22 Apr 2011

Therapy News and Research

Nausea and vomiting are most feared of all chemotherapy-related side effects

Enrollment commences in Gore Early TIPS study for ascites at Indiana University Hospital

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

New genetic discovery in Pulmonary Fibrosis

U-M receives Taubman Institute's $100 million gift for innovative medical science

Group B streptococci continues to increase risk of sepsis in newborns

Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress

Medtronic's English Channel swimming competition to raise awareness on ALS

Study shows neutralizing antibodies against GM-CSF can halt MS development

Creative approach can tackle bacterial infections in patients with cystic fibrosis

JVIR articles highlight SIR's commitment to patient safety in medical imaging

Saint Vincent Hospital to build new cancer center in downtown Worcester

Live surgical procedure to repair abdominal aortic aneurysm broadcast to CICE 2011 in Sao Paolo, Brazil

Transplanting cells from healthy adult livers may help treat genetic liver-lung disorder

HHS awards Eigen two grants from Qualifying Therapeutic Discovery Project

Giffords' office: Close gap in traumatic brain-injury care

Research solves challenging problem of industry-scale production of large RNA molecules

Teva acknowledges promising results of DEFINE study in MS

BioCryst's BCX4208 study results in gout to be presented at EULAR meeting

Decision Resources: 63% of neurologists select Tysabri as effective MS treatment

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News